Skip to main content
. 2014 Jun 13;9(6):e99625. doi: 10.1371/journal.pone.0099625

Table 2. SNPs within 50Table 1 that are associated (overall P-value <1E-03) with bronchodilator response (BDR) or inhaled corticosteroid (ICS) resistance in human clinical trial cohorts.

CHR SNP BP A1 A2 A1 FREQ P-value Gene Phenotype
5 rs13155012 150546065 G A 0.93, 0.94, 0.94 7.6E-04 CCDC69 BDR
16 rs58151657 84867507 G A 0.85, 0.88, 0.88 1.6E-04 CRISPLD2 BDR
16 rs8047416 84871409 C T 0.88, 0.88, 0.88 4.4E-04 CRISPLD2 BDR
16 rs7189551 84958011 T C 0.76, 0.76, 0.72, 0.78 7.8E-04 CRISPLD2 ICS Resistance
16 rs7188498 84958018 G A 0.76, 0.75, 0.71, 0.78 5.1E-04 CRISPLD2 ICS Resistance
16 rs9928433 84958414 A G 0.78, 0.80, 0.78, 0.84 5.8E-04 CRISPLD2 ICS Resistance
16 rs67343076 84964590 G A 0.76, 0.78, 0.77, 0.83 3.3E-04 CRISPLD2 ICS Resistance
16 rs8061778 84986714 G T 0.86, 0.84, 0.84, 0.79 7.5E-04 CRISPLD2 ICS Resistance

A1 FREQ lists frequencies from individual cohorts used to compute overall P-value for each phenotype.